Global Radiation Oncology Treatment Planning Software Market By Offering (Software (On Premise, Cloud), Service); By Therapy Type (Stereotactic Radiosurgery (SRS), 3-D Conformal Radiation Therapy (3D CRT), Brachytherapy, Stereotactic Body Radiotherapy (SBRT), Intensity modulated radiation therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT),Others); By End-User (Small and Medium Organizations, Large Organizations); By End-Users (Hospitals, Clinics, Cancer Treatment Centres, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia(Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia) Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Global radiation oncology treatment planning software market is projected to be driven by the increasing prevalence of cancer globally. As per the National Cancer Centre, 1,806,590 new cases of cancer were estimated to be diagnosed in the United States and 606,520 people were predicted to die from the disease. The most common cancers are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin and ranks as a leading cause of death. This rising prevalence has created a need for effective and advance treatment line. Also, with increasing research and development, the treatment for cancer have evolved, therefore the deployment of planning software by hospitals and cancer centre is increasing rapidly for providing accurate and fast treatment. Also, it delivers advanced care, and reduces human errors. The modern radiation therapy treatment planning and delivery is a complex process which relies on advanced imaging and computing technology, thereby creating a need for treatment planning software. The process includes simulation imaging, in which three-dimensional computed tomography images are used to characterize the patient anatomy.
Technological advancements, growing public and private investments, funding, and grants is further driving the global radiation oncology treatment planning software market. For instance, Mirada Medical has raised funds of £6 million into new AI-based imaging software to lead the transformation of radiation oncology, aiming to increase speed and accuracy of cancer treatment planning applications. Furthermore, developing IT infrastructure, rising adoption of artificial intelligence and machine learning into oncology treatment software to enhance the diagnosis, treatment plan, and cancer care management is impelling the market’s growth.
The key players in the market are focusing on the development of innovative and advanced solutions to meet the growing demand for accurate oncology treatment solutions. For instance, in 2019, Synchrony motion tracking and correction technology for its Radixact system was launched by Accuray. Additionally, increasing collaboration to expand and strengthen the market is further impacting the market growth. For instance, in 2019, MIM Software also announced a new collaboration with Philips Healthcare to provide an integrated portfolio of imaging and treatment planning solutions. The outbreak of COVID-19 pandemic had a significant impact on global radiation oncology treatment planning software as many radiations therapy session were cancelled or postponed with an intent of controlling the spread of coronavirus. However, with the improving situation and resuming of other treatments, the radiation oncology treatment planning software market is anticipated to witness a lucrative growth over the forecast period.
In terms of revenue, the global radiation oncology treatment planning software market is growing at a CAGR of 8.9% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Radiation Oncology Treatment Planning Software Market Revenue & Forecast, (US$ Million), 2015 – 2030
Offering Outlook:
Based on the offering, the global radiation oncology treatment planning software market has been segmented into software and services. The software segment dominated the radiation oncology treatment planning software market in 2021 owing to its increasing demand to enhance patient outcomes. Moreover, the increasing awareness regarding its efficiency in cancer treatment using radiotherapy is driving the segment’s growth. This software helps to reduce the preparation time of a patient’s treatment plan, decrease plan variation and improve healthy tissue sparing compared with manual planning. For instance, RaySearch offers RayStation which is designed for 4-D adaptive radiation therapy as a built-in generic feature and it incorporates the latest techniques for proton therapy. Also, it contains tools for multi-criteria optimization, enabling a much more intuitive treatment planning process.
Therapy type Outlook:
Based on therapy type, the global radiation oncology treatment planning software market is bifurcated into Stereotactic Radiosurgery (SRS), 3-D Conformal Radiation Therapy (3D CRT), Brachytherapy, Stereotactic Body Radiotherapy (SBRT), Intensity modulated radiation therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT) and Others. The volumetric modulated arc therapy (VMAT) segment accounted for the highest market share in radiation oncology treatment planning software market in 2021. The growth in this segment can be attributed to the advantages offered by this technique such as it accurately shapes the radiation dose to the tumour while minimising the dose to the organs surrounding the tumour. It also allows for fast delivery of radiation treatment and results in improved conformality and reduces the chance of error due to intra-fraction motion.
Organization Size Outlook:
Based on organization size, the global radiation oncology treatment planning software market is bifurcated into small and medium size organization and large size organization. The large size organization segment dominated the market in 2021, due to increasing investments by them for the development of treatment planning software. Also, they are increasingly focusing on innovative product development, thereby driving the segment’s growth. For instance, the Cancer Imaging Archive or Creative Commons organization offers services and/or licenses for data sharing.
End-User Outlook:
Based on end-user, the global radiation oncology treatment planning software market is bifurcated into hospitals, clinics and cancer treatment centres. Hospitals held the largest market share in 2021 in radiation oncology treatment planning software market owing to the higher inflow of cancer patients. The radiotherapies are extensively conducted in hospitals and the availability of facilities for diagnosis, treatment, and disease management, as well as trained personnel is driving its growth. Moreover, the growing number of hospitals across the countries is positively impacting the market growth.
Region Outlook:
Based on regions, North America dominated the market in 2021, owing to the presence of well-developed healthcare infrastructure, increasing number of cancer patients and presence of key players in the region are factors propelling the radiation oncology treatment planning software market.
Competitive Landscape
The report provides both, qualitative and quantitative research of radiation oncology treatment planning software market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the key players operating in the global radiation oncology treatment planning software market are:
- Accuray Incorporated
- Brainlab
- Cerner Corporation
- Elekta AB (pub)
- GMV GROUP
- Koninklijke Philips N.V.
- Prowess Inc.
- RaySearch Laboratories
- Siemens Healthcare Private Limited
- Varian Medical Systems, Inc
- Other Market Participants
Global Radiation Oncology Treatment Planning Software Market
By Offering
- Software
- On Premise
- Cloud
- Services
By Therapy Type
- Stereotactic Radiosurgery (SRS)
- 3-D Conformal Radiation Therapy (3D CRT)
- Brachytherapy
- Stereotactic Body Radiotherapy (SBRT)
- Intensity modulated radiation therapy (IMRT)
- Volumetric Modulated Arc Therapy (VMAT)
- Others
By Organization Size
- Small and Medium Organizations
- Large Organizations
By End Users
- Hospitals
- Clinics
- Cancer Treatment Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1.
Historic Years: 2015 - 2020
1.2.2.
Base Year: 2021
1.2.3.
Forecast Years: 2022 – 2030
2.
Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2.
Global Percentage Breakdown
3.1.3.
Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2.
Secondary Sources
3.3. Market Size Estimates
3.3.1.
Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5. Holistic Overview
of Radiation Oncology Treatment Planning Software Market
6.
Market Synopsis: Radiation Oncology Treatment Planning
Software Market
7. Radiation Oncology Treatment
Planning Software Market
Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2.
Industry Development
7.2. Market Dynamics
7.2.1.
Drivers
7.2.2. Restraints
7.2.3.
Opportunities
7.3. Trends in Radiation Oncology
Treatment Planning Software
Market
7.4. Market Determinants Radar Chart
7.5.
Macro-Economic and Micro-Economic Indicators:
Radiation Oncology Treatment Planning Software Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Radiation Oncology
Treatment Planning Software
Market
8. Global
Radiation Oncology Treatment Planning Software Market Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1.
Global Radiation Oncology
Treatment Planning Software
Market Revenue (US$ Mn)
8.2.
Global Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
8.2.1.
Software (Definition, Market Estimation and
Penetration, 2015 – 2021, Market Estimation
(2015 – 2021), Market Forecast (2022 – 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation
(North America, Europe, Asia Pacific, Middle East and Africa,
Latin America) and Information
on On Premise, Cloud)
8.2.1.1.
On Premise
8.2.1.2.
Cloud
8.2.2. Services
8.2.2.1.
Definition
8.2.2.2.
Market Estimation and Penetration,
2015 – 2021
8.2.2.3.
Market Forecast, 2022 – 2030
8.2.2.4.
Compound Annual Growth Rate (CAGR)
8.2.2.5.
Regional Bifurcation
8.2.2.5.1.
North America
8.2.2.5.1.1.
Market Estimation, 2015 – 2021
8.2.2.5.1.2.
Market Forecast, 2022 – 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1.
Market Estimation, 2015 – 2021
8.2.2.5.2.2.
Market Forecast, 2022 – 2030
8.2.2.5.3.
Asia Pacific
8.2.2.5.3.1.
Market Estimation, 2015 – 2021
8.2.2.5.3.2.
Market Forecast, 2022 – 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1.
Market Estimation, 2015 – 2021
8.2.2.5.4.2.
Market Forecast, 2022 – 2030
8.2.2.5.5.
Latin America
8.2.2.5.5.1.
Market Estimation, 2015 – 2021
8.2.2.5.5.2.
Market Forecast, 2022 – 2030
8.3. Key Segment
for Channeling Investments
8.3.1. By Offering
9. Global
Radiation Oncology Treatment Planning Software Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2.
Global Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
9.2.1. Stereotactic Radiosurgery (SRS)
9.2.1.1.
Definition
9.2.1.2.
Market Estimation and Penetration,
2015 – 2021
9.2.1.3.
Market Forecast, 2022 – 2030
9.2.1.4.
Compound Annual Growth Rate (CAGR)
9.2.1.5.
Regional Bifurcation
9.2.1.5.1.
North America
9.2.1.5.1.1.
Market Estimation, 2015 – 2021
9.2.1.5.1.2.
Market Forecast, 2022 – 2030
9.2.1.5.2. Europe
9.2.1.5.2.1.
Market Estimation, 2015 – 2021
9.2.1.5.2.2.
Market Forecast, 2022 – 2030
9.2.1.5.3.
Asia Pacific
9.2.1.5.3.1.
Market Estimation, 2015 – 2021
9.2.1.5.3.2.
Market Forecast, 2022 – 2030
9.2.1.5.4.
Middle East and Africa
9.2.1.5.4.1.
Market Estimation, 2015 – 2021
9.2.1.5.4.2.
Market Forecast, 2022 – 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1.
Market Estimation, 2015 – 2021
9.2.1.5.5.2.
Market Forecast, 2022 – 2030
9.2.2. 3-D Conformal Radiation Therapy
(3D CRT)
9.2.2.1.
Definition
9.2.2.2.
Market Estimation and Penetration,
2015 – 2021
9.2.2.3.
Market Forecast, 2022 – 2030
9.2.2.4.
Compound Annual Growth Rate (CAGR)
9.2.2.5.
Regional Bifurcation
9.2.2.5.1.
North America
9.2.2.5.1.1.
Market Estimation, 2015 – 2021
9.2.2.5.1.2.
Market Forecast, 2022 – 2030
9.2.2.5.2. Europe
9.2.2.5.2.1.
Market Estimation, 2015 – 2021
9.2.2.5.2.2.
Market Forecast, 2022 – 2030
9.2.2.5.3.
Asia Pacific
9.2.2.5.3.1.
Market Estimation, 2015 – 2021
9.2.2.5.3.2.
Market Forecast, 2022 – 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1.
Market Estimation, 2015 – 2021
9.2.2.5.4.2.
Market Forecast, 2022 – 2030
9.2.2.5.5.
Latin America
9.2.2.5.5.1.
Market Estimation, 2015 – 2021
9.2.2.5.5.2.
Market Forecast, 2022 – 2030
9.2.3.
Brachytherapy
9.2.3.1.
Definition
9.2.3.2.
Market Estimation and Penetration,
2015 – 2021
9.2.3.3.
Market Forecast, 2022 – 2030
9.2.3.4.
Compound Annual Growth Rate (CAGR)
9.2.3.5.
Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1.
Market Estimation, 2015 – 2021
9.2.3.5.1.2.
Market Forecast, 2022 – 2030
9.2.3.5.2. Europe
9.2.3.5.2.1.
Market Estimation, 2015 – 2021
9.2.3.5.2.2.
Market Forecast, 2022 – 2030
9.2.3.5.3.
Asia Pacific
9.2.3.5.3.1.
Market Estimation, 2015 – 2021
9.2.3.5.3.2.
Market Forecast, 2022 – 2030
9.2.3.5.4.
Middle East and Africa
9.2.3.5.4.1.
Market Estimation, 2015 – 2021
9.2.3.5.4.2.
Market Forecast, 2022 – 2030
9.2.3.5.5.
Latin America
9.2.3.5.5.1.
Market Estimation, 2015 – 2021
9.2.3.5.5.2.
Market Forecast, 2022 – 2030
9.2.4. Stereotactic Body Radiotherapy (SBRT)
9.2.4.1.
Definition
9.2.4.2.
Market Estimation and Penetration,
2015 – 2021
9.2.4.3.
Market Forecast, 2022 – 2030
9.2.4.4.
Compound Annual Growth Rate (CAGR)
9.2.4.5.
Regional Bifurcation
9.2.4.5.1.
North America
9.2.4.5.1.1.
Market Estimation, 2015 – 2021
9.2.4.5.1.2.
Market Forecast, 2022 – 2030
9.2.4.5.2.
Europe
9.2.4.5.2.1.
Market Estimation, 2015 – 2021
9.2.4.5.2.2.
Market Forecast, 2022 – 2030
9.2.4.5.3.
Asia Pacific
9.2.4.5.3.1.
Market Estimation, 2015 – 2021
9.2.4.5.3.2.
Market Forecast, 2022 – 2030
9.2.4.5.4.
Middle East and Africa
9.2.4.5.4.1.
Market Estimation, 2015 – 2021
9.2.4.5.4.2.
Market Forecast, 2022 – 2030
9.2.4.5.5.
Latin America
9.2.4.5.5.1.
Market Estimation, 2015 – 2021
9.2.4.5.5.2.
Market Forecast, 2022 – 2030
9.2.5. Intensity modulated radiation therapy (IMRT)
9.2.5.1.
Definition
9.2.5.2.
Market Estimation and Penetration,
2015 – 2021
9.2.5.3.
Market Forecast, 2022 – 2030
9.2.5.4.
Compound Annual Growth Rate (CAGR)
9.2.5.5.
Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1.
Market Estimation, 2015 – 2021
9.2.5.5.1.2.
Market Forecast, 2022 – 2030
9.2.5.5.2.
Europe
9.2.5.5.2.1.
Market Estimation, 2015 – 2021
9.2.5.5.2.2.
Market Forecast, 2022 – 2030
9.2.5.5.3.
Asia Pacific
9.2.5.5.3.1.
Market Estimation, 2015 – 2021
9.2.5.5.3.2.
Market Forecast, 2022 – 2030
9.2.5.5.4.
Middle East and Africa
9.2.5.5.4.1.
Market Estimation, 2015 – 2021
9.2.5.5.4.2.
Market Forecast, 2022 – 2030
9.2.5.5.5. Latin America
9.2.5.5.5.1.
Market Estimation, 2015 – 2021
9.2.5.5.5.2.
Market Forecast, 2022 – 2030
9.2.6.
Volumetric Modulated Arc Therapy (VMAT)
9.2.6.1.
Definition
9.2.6.2.
Market Estimation and Penetration,
2015 – 2021
9.2.6.3.
Market Forecast, 2022 – 2030
9.2.6.4.
Compound Annual Growth Rate (CAGR)
9.2.6.5.
Regional Bifurcation
9.2.6.5.1.
North America
9.2.6.5.1.1.
Market Estimation, 2015 – 2021
9.2.6.5.1.2.
Market Forecast, 2022 – 2030
9.2.6.5.2.
Europe
9.2.6.5.2.1.
Market Estimation, 2015 – 2021
9.2.6.5.2.2.
Market Forecast, 2022 – 2030
9.2.6.5.3.
Asia Pacific
9.2.6.5.3.1.
Market Estimation, 2015 – 2021
9.2.6.5.3.2.
Market Forecast, 2022 – 2030
9.2.6.5.4.
Middle East and Africa
9.2.6.5.4.1.
Market Estimation, 2015 – 2021
9.2.6.5.4.2.
Market Forecast, 2022 – 2030
9.2.6.5.5. Latin America
9.2.6.5.5.1.
Market Estimation, 2015 – 2021
9.2.6.5.5.2.
Market Forecast, 2022 – 2030
9.2.7. Others
9.2.7.1.
Definition
9.2.7.2.
Market Estimation and Penetration,
2015 – 2021
9.2.7.3.
Market Forecast, 2022 – 2030
9.2.7.4.
Compound Annual Growth Rate (CAGR)
9.2.7.5.
Regional Bifurcation
9.2.7.5.1.
North America
9.2.7.5.1.1.
Market Estimation, 2015 – 2021
9.2.7.5.1.2.
Market Forecast, 2022 – 2030
9.2.7.5.2.
Europe
9.2.7.5.2.1.
Market Estimation, 2015 – 2021
9.2.7.5.2.2.
Market Forecast, 2022 – 2030
9.2.7.5.3.
Asia Pacific
9.2.7.5.3.1.
Market Estimation, 2015 – 2021
9.2.7.5.3.2.
Market Forecast, 2022 – 2030
9.2.7.5.4. Middle East and Africa
9.2.7.5.4.1.
Market Estimation, 2015 – 2021
9.2.7.5.4.2.
Market Forecast, 2022 – 2030
9.2.7.5.5.
Latin America
9.2.7.5.5.1.
Market Estimation, 2015 – 2021
9.2.7.5.5.2.
Market Forecast, 2022 – 2030
9.3. Key Segment
for Channeling Investments
9.3.1. By Therapy Type
10. Global
Radiation Oncology Treatment Planning Software Market Analysis and Forecasts, 2022 – 2030
10.1. Overview
10.2.
Global Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
10.2.1. Small and Medium
Organizations
10.2.1.1.
Definition
10.2.1.2.
Market Estimation and Penetration,
2015 – 2021
10.2.1.3.
Market Forecast, 2022 – 2030
10.2.1.4.
Compound Annual Growth Rate (CAGR)
10.2.1.5.
Regional Bifurcation
10.2.1.5.1.
North America
10.2.1.5.1.1.
Market Estimation, 2015 – 2021
10.2.1.5.1.2.
Market Forecast, 2022 – 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1.
Market Estimation, 2015 – 2021
10.2.1.5.2.2.
Market Forecast, 2022 – 2030
10.2.1.5.3.
Asia Pacific
10.2.1.5.3.1.
Market Estimation, 2015 – 2021
10.2.1.5.3.2.
Market Forecast, 2022 – 2030 10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1.
Market Estimation, 2015 – 2021
10.2.1.5.4.2.
Market Forecast, 2022 – 2030
10.2.1.5.5.
Latin America
10.2.1.5.5.1.
Market Estimation, 2015 – 2021
10.2.1.5.5.2.
Market Forecast, 2022 – 2030
10.2.2. Large Organizations
10.2.2.1.
Definition
10.2.2.2.
Market Estimation and Penetration,
2015 – 2021
10.2.2.3.
Market Forecast, 2022 – 2030
10.2.2.4.
Compound Annual Growth
Rate (CAGR)
10.2.2.5.
Regional Bifurcation
10.2.2.5.1.
North America
10.2.2.5.1.1.
Market Estimation, 2015 – 2021
10.2.2.5.1.2.
Market Forecast, 2022 – 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1.
Market Estimation, 2015 – 2021
10.2.2.5.2.2.
Market Forecast, 2022 – 2030
10.2.2.5.3.
Asia Pacific
10.2.2.5.3.1.
Market Estimation, 2015 – 2021
10.2.2.5.3.2.
Market Forecast, 2022 – 2030 10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market Estimation, 2015 – 2021
10.2.2.5.4.2.
Market Forecast, 2022 – 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1.
Market Estimation, 2015 – 2021
10.2.2.5.5.2.
Market Forecast, 2022 – 2030
10.3. Key Segment
for Channeling Investments
10.3.1. By Organization Size
11. Global
Radiation Oncology Treatment Planning Software Market Analysis and Forecasts, 2022 – 2030
11.1. Overview
11.2.
Global Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
11.2.1. Hospitals
11.2.1.1.
Definition
11.2.1.2.
Market Estimation and Penetration,
2015 – 2021
11.2.1.3.
Market Forecast, 2022 – 2030
11.2.1.4.
Compound Annual Growth Rate (CAGR)
11.2.1.5.
Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1.
Market Estimation, 2015 – 2021
11.2.1.5.1.2.
Market Forecast, 2022 – 2030
11.2.1.5.2.
Europe
11.2.1.5.2.1.
Market Estimation, 2015 – 2021
11.2.1.5.2.2.
Market Forecast, 2022 – 2030
11.2.1.5.3.
Asia Pacific
11.2.1.5.3.1.
Market Estimation, 2015 – 2021
11.2.1.5.3.2.
Market Forecast, 2022 – 2030 11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market Estimation, 2015 – 2021
11.2.1.5.4.2.
Market Forecast, 2022 – 2030
11.2.1.5.5.
Latin America
11.2.1.5.5.1.
Market Estimation, 2015 – 2021
11.2.1.5.5.2. Market Forecast, 2022 – 2030
11.2.2.
Clinics
11.2.2.1.
Definition
11.2.2.2.
Market Estimation and Penetration, 2015 – 2021
11.2.2.3.
Market Forecast, 2022 – 2030
11.2.2.4.
Compound Annual Growth Rate (CAGR)
11.2.2.5.
Regional Bifurcation
11.2.2.5.1.
North America
11.2.2.5.1.1.
Market Estimation, 2015 – 2021
11.2.2.5.1.2.
Market Forecast, 2022 – 2030
11.2.2.5.2. Europe
11.2.2.5.2.1.
Market Estimation, 2015 – 2021
11.2.2.5.2.2.
Market Forecast, 2022 – 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1.
Market Estimation, 2015 – 2021
11.2.2.5.3.2.
Market Forecast, 2022 – 2030 11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market Estimation, 2015 – 2021
11.2.2.5.4.2.
Market Forecast, 2022 – 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1.
Market Estimation, 2015 – 2021
11.2.2.5.5.2. Market Forecast, 2022 – 2030
11.2.3.
Cancer Treatment Centers
11.2.3.1.
Definition
11.2.3.2.
Market Estimation and Penetration,
2015 – 2021
11.2.3.3.
Market Forecast, 2022 – 2030
11.2.3.4.
Compound Annual Growth Rate (CAGR)
11.2.3.5.
Regional Bifurcation
11.2.3.5.1.
North America
11.2.3.5.1.1.
Market Estimation, 2015 – 2021
11.2.3.5.1.2.
Market Forecast, 2022 – 2030
11.2.3.5.2.
Europe
11.2.3.5.2.1.
Market Estimation, 2015 – 2021
11.2.3.5.2.2.
Market Forecast, 2022 – 2030
11.2.3.5.3.
Asia Pacific
11.2.3.5.3.1.
Market Estimation, 2015 – 2021
11.2.3.5.3.2.
Market Forecast, 2022 – 2030 11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market Estimation, 2015 – 2021
11.2.3.5.4.2. Market Forecast, 2022 – 2030
11.2.3.5.5.
Latin America
11.2.3.5.5.1. Market Estimation, 2015 – 2021
11.2.3.5.5.2.
Market Forecast, 2022 – 2030
11.2.4.
Others
11.2.4.1.
Definition
11.2.4.2.
Market Estimation and Penetration,
2015 – 2021
11.2.4.3.
Market Forecast, 2022 – 2030
11.2.4.4.
Compound Annual Growth Rate (CAGR)
11.2.4.5.
Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1.
Market Estimation, 2015 – 2021
11.2.4.5.1.2.
Market Forecast, 2022 – 2030
11.2.4.5.2. Europe
11.2.4.5.2.1.
Market Estimation, 2015 – 2021
11.2.4.5.2.2.
Market Forecast, 2022 – 2030
11.2.4.5.3.
Asia Pacific
11.2.4.5.3.1.
Market Estimation, 2015 – 2021
11.2.4.5.3.2.
Market Forecast, 2022 – 2030 11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market Estimation, 2015 – 2021
11.2.4.5.4.2. Market Forecast, 2022 – 2030
11.2.4.5.5.
Latin America
11.2.4.5.5.1.
Market Estimation, 2015 – 2021
11.2.4.5.5.2.
Market Forecast, 2022 – 2030
11.3. Key Segment
for Channeling Investments
11.3.1. By End Users
12. North
America Radiation Oncology Treatment Planning Software Market Analysis and Forecasts, 2022 - 2030
12.1. Overview
12.1.1.
North America Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn)
12.2.
North America Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Offering
12.2.1. Software
12.2.1.1.
On Premise
12.2.1.2.
Cloud
12.2.2.
Services
12.3.
North America Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
12.3.1. Stereotactic Radiosurgery (SRS)
12.3.2.
3-D Conformal Radiation Therapy (3D CRT)
12.3.3. Brachytherapy
12.3.4.
Stereotactic Body Radiotherapy (SBRT)
12.3.5. Intensity modulated radiation therapy (IMRT)
12.3.6.
Volumetric Modulated Arc Therapy (VMAT)
12.3.7.
Others
12.4.
North America Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Organization Size
12.4.1. Small and Medium
Organizations
12.4.2. Large Organizations
12.5.
North America Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1. Hospitals
12.5.2.
Clinics
12.5.3. Cancer Treatment Centers
12.5.4.
Others
12.6.
North America Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1.
U.S Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
12.6.1.1.1. Software
12.6.1.1.1.1.
On Premise
12.6.1.1.1.2.
Cloud
12.6.1.1.2.
Services
12.6.1.2.
U.S Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
12.6.1.2.1. Stereotactic Radiosurgery (SRS)
12.6.1.2.2.
3-D Conformal Radiation Therapy (3D CRT) 12.6.1.2.3. Brachytherapy
12.6.1.2.4.
Stereotactic Body Radiotherapy (SBRT) 12.6.1.2.5.
Intensity modulated radiation therapy (IMRT)
12.6.1.2.6. Volumetric Modulated Arc Therapy (VMAT) 12.6.1.2.7. Others
12.6.1.3.
U.S Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
12.6.1.3.1.
Small and Medium Organizations 12.6.1.3.2. Large Organizations
12.6.1.4.
U.S Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.1.4.1. Hospitals
12.6.1.4.2. Clinics
12.6.1.4.3.
Cancer Treatment Centers 12.6.1.4.4. Others
12.6.2. Canada
12.6.2.1.
Canada Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
12.6.2.1.1. Software
12.6.2.1.1.1.
On Premise
12.6.2.1.1.2.
Cloud
12.6.2.1.2.
Services
12.6.2.2.
Canada Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
12.6.2.2.1. Stereotactic Radiosurgery (SRS)
12.6.2.2.2.
3-D Conformal Radiation Therapy (3D CRT) 12.6.2.2.3. Brachytherapy
12.6.2.2.4.
Stereotactic Body Radiotherapy (SBRT) 12.6.2.2.5.
Intensity modulated radiation therapy (IMRT)
12.6.2.2.6. Volumetric Modulated Arc Therapy (VMAT) 12.6.2.2.7. Others
12.6.2.3.
Canada Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
12.6.2.3.1.
Small and Medium Organizations 12.6.2.3.2. Large Organizations
12.6.2.4.
Canada Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.2.4.1. Hospitals
12.6.2.4.2.
Clinics
12.6.2.4.3.
Cancer Treatment Centers 12.6.2.4.4. Others
12.6.3. Mexico
12.6.3.1.
Mexico Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
12.6.3.1.1. Software
12.6.3.1.1.1.
On Premise
12.6.3.1.1.2.
Cloud
12.6.3.1.2.
Services
12.6.3.2.
Mexico Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
12.6.3.2.1. Stereotactic Radiosurgery (SRS)
12.6.3.2.2.
3-D Conformal Radiation Therapy (3D CRT) 12.6.3.2.3. Brachytherapy
12.6.3.2.4.
Stereotactic Body Radiotherapy (SBRT) 12.6.3.2.5.
Intensity modulated radiation therapy (IMRT)
12.6.3.2.6. Volumetric Modulated Arc Therapy (VMAT) 12.6.3.2.7. Others
12.6.3.3.
Mexico Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
12.6.3.3.1.
Small and Medium Organizations 12.6.3.3.2. Large Organizations
12.6.3.4.
Mexico Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.3.4.1. Hospitals
12.6.3.4.2.
Clinics
12.6.3.4.3.
Cancer Treatment Centers 12.6.3.4.4. Others
12.6.4. Rest of North America
12.6.4.1.
Rest of North America Radiation Oncology Treatment
Planning Software Market Revenue
(US$ Mn) and Forecasts, By Offering
12.6.4.1.1. Software
12.6.4.1.1.1.
On Premise
12.6.4.1.1.2.
Cloud
12.6.4.1.2.
Services
12.6.4.2.
Rest of North America Radiation Oncology Treatment
Planning Software Market Revenue
(US$ Mn) and Forecasts, By Therapy Type
12.6.4.2.1. Stereotactic Radiosurgery (SRS)
12.6.4.2.2.
3-D Conformal Radiation Therapy (3D CRT) 12.6.4.2.3. Brachytherapy
12.6.4.2.4.
Stereotactic Body Radiotherapy (SBRT) 12.6.4.2.5.
Intensity modulated radiation therapy (IMRT)
12.6.4.2.6. Volumetric Modulated Arc Therapy (VMAT) 12.6.4.2.7. Others
12.6.4.3.
Rest of North America Radiation Oncology Treatment
Planning Software Market Revenue (US$ Mn) and Forecasts, By Organization Size
12.6.4.3.1.
Small and Medium Organizations 12.6.4.3.2. Large Organizations
12.6.4.4.
Rest of North America Radiation Oncology Treatment
Planning Software Market Revenue
(US$ Mn) and Forecasts, By End Users
12.6.4.4.1. Hospitals
12.6.4.4.2.
Clinics
12.6.4.4.3.
Cancer Treatment Centers 12.6.4.4.4. Others
12.7. Key Segment for Channeling Investments
12.7.1.
By Country
12.7.2.
By Offering
12.7.3. By Therapy Type
12.7.4.
By Organization Size
12.7.5.
By End Users
13. Europe
Radiation Oncology Treatment Planning Software Market Analysis and Forecasts, 2022 - 2030
13.1. Overview
13.1.1.
Europe Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn)
13.2.
Europe Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
13.2.1. Software
13.2.1.1.
On Premise
13.2.1.2.
Cloud
13.2.2.
Services
13.3.
Europe Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
13.3.1. Stereotactic Radiosurgery (SRS)
13.3.2. 3-D Conformal Radiation Therapy
(3D CRT)
13.3.3.
Brachytherapy
13.3.4.
Stereotactic Body Radiotherapy (SBRT)
13.3.5.
Intensity modulated radiation therapy (IMRT)
13.3.6.
Volumetric Modulated Arc Therapy (VMAT)
13.3.7. Others
13.4.
Europe Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
13.4.1. Small and Medium
Organizations
13.4.2.
Large Organizations
13.5.
Europe Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1. Hospitals
13.5.2. Clinics
13.5.3.
Cancer Treatment Centers
13.5.4.
Others
13.6.
Europe Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1.
France Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.1.1.1. Software
13.6.1.1.1.1.
On Premise
13.6.1.1.1.2.
Cloud
13.6.1.1.2. Services
13.6.1.2.
France Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
13.6.1.2.1. Stereotactic Radiosurgery (SRS)
13.6.1.2.2.
3-D Conformal Radiation Therapy (3D CRT) 13.6.1.2.3. Brachytherapy
13.6.1.2.4.
Stereotactic Body Radiotherapy (SBRT) 13.6.1.2.5.
Intensity modulated radiation therapy (IMRT)
13.6.1.2.6. Volumetric Modulated Arc Therapy (VMAT) 13.6.1.2.7. Others
13.6.1.3.
France Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
13.6.1.3.1.
Small and Medium Organizations 13.6.1.3.2. Large Organizations
13.6.1.4.
France Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.1.4.1. Hospitals
13.6.1.4.2. Clinics
13.6.1.4.3.
Cancer Treatment Centers 13.6.1.4.4. Others
13.6.2. The UK
13.6.2.1.
The UK Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.2.1.1. Software
13.6.2.1.1.1.
On Premise
13.6.2.1.1.2.
Cloud
13.6.2.1.2.
Services
13.6.2.2.
The UK Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
13.6.2.2.1. Stereotactic Radiosurgery (SRS)
13.6.2.2.2.
3-D Conformal Radiation Therapy (3D CRT) 13.6.2.2.3. Brachytherapy
13.6.2.2.4.
Stereotactic Body Radiotherapy (SBRT) 13.6.2.2.5.
Intensity modulated radiation therapy (IMRT)
13.6.2.2.6. Volumetric Modulated Arc Therapy (VMAT) 13.6.2.2.7. Others
13.6.2.3.
The UK Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
13.6.2.3.1.
Small and Medium Organizations 13.6.2.3.2. Large Organizations
13.6.2.4.
The UK Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.2.4.1. Hospitals
13.6.3. Spain
13.6.3.1.1.
Clinics
13.6.3.1.2.
Cancer Treatment Centers 13.6.2.4.4. Others
13.6.3.2.
Spain Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.3.2.1. Software
13.6.3.2.1.1.
On Premise
13.6.3.2.1.2.
Cloud
13.6.3.2.2.
Services
13.6.3.3.
Spain Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
13.6.3.3.1. Stereotactic Radiosurgery (SRS)
13.6.3.3.2.
3-D Conformal Radiation Therapy (3D CRT) 13.6.3.2.3. Brachytherapy
13.6.3.2.4.
Stereotactic Body Radiotherapy (SBRT) 13.6.3.2.5.
Intensity modulated radiation therapy (IMRT)
13.6.3.2.6. Volumetric Modulated Arc Therapy (VMAT) 13.6.3.2.7. Others
13.6.3.4.
Spain Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
13.6.3.4.1.
Small and Medium Organizations 13.6.3.3.2. Large Organizations
13.6.3.5.
Spain Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.3.5.1. Hospitals
13.6.3.5.2.
Clinics
13.6.3.5.3.
Cancer Treatment Centers 13.6.3.4.4. Others
13.6.4. Germany
13.6.4.1.
Germany Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.4.1.1. Software
13.6.4.1.1.1.
On Premise
13.6.4.1.1.2.
Cloud
13.6.4.1.2.
Services
13.6.4.2.
Germany Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
13.6.4.2.1. Stereotactic Radiosurgery (SRS)
13.6.4.2.2.
3-D Conformal Radiation Therapy (3D CRT)
13.6.4.2.3. Brachytherapy
13.6.4.2.4.
Stereotactic Body Radiotherapy (SBRT) 13.6.4.2.5. Intensity modulated radiation
therapy (IMRT) 13.6.4.2.6.
Volumetric Modulated Arc Therapy (VMAT) 13.6.4.2.7. Others
13.6.4.3.
Germany Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization
Size
13.6.4.3.1.
Small and Medium Organizations 13.6.4.3.2. Large Organizations
13.6.4.4.
Germany Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.4.4.1. Hospitals
13.6.4.4.2. Clinics
13.6.4.4.3.
Cancer Treatment Centers 13.6.4.4.4. Others
13.6.5. Italy
13.6.5.1.
Italy Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.5.1.1. Software
13.6.5.1.1.1.
On Premise
13.6.5.1.1.2.
Cloud
13.6.5.1.2. Services
13.6.5.2.
Italy Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
13.6.5.2.1. Stereotactic Radiosurgery (SRS)
13.6.5.2.2.
3-D Conformal Radiation Therapy (3D CRT) 13.6.5.2.3. Brachytherapy
13.6.5.2.4.
Stereotactic Body Radiotherapy (SBRT) 13.6.5.2.5.
Intensity modulated radiation therapy (IMRT)
13.6.5.2.6. Volumetric Modulated Arc Therapy (VMAT) 13.6.5.2.7. Others
13.6.5.3.
Italy Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
13.6.5.3.1.
Small and Medium Organizations 13.6.5.3.2. Large Organizations
13.6.5.4.
Italy Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.5.4.1. Hospitals
13.6.5.4.2.
Clinics
13.6.5.4.3.
Cancer Treatment Centers
13.6.5.4.4. Others
13.6.6. Nordic Countries
13.6.6.1.
Nordic Countries Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.6.1.1. Software
13.6.6.1.1.1.
On Premise
13.6.6.1.1.2.
Cloud
13.6.6.1.2.
Services
13.6.6.2.
Nordic Countries Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
13.6.6.2.1. Stereotactic Radiosurgery (SRS)
13.6.6.2.2.
3-D Conformal Radiation Therapy (3D CRT) 13.6.6.2.3. Brachytherapy
13.6.6.2.4.
Stereotactic Body Radiotherapy (SBRT) 13.6.6.2.5.
Intensity modulated radiation therapy (IMRT)
13.6.6.2.6. Volumetric Modulated Arc Therapy (VMAT) 13.6.6.2.7. Others
13.6.6.3.
Nordic Countries Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Organization Size
13.6.6.3.1.
Small and Medium Organizations 13.6.6.3.2. Large Organizations
13.6.6.4.
Nordic Countries Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.6.4.1. Hospitals
13.6.6.4.2.
Clinics
13.6.6.4.3.
Cancer Treatment Centers 13.6.6.4.4. Others
13.6.6.5.
Nordic Countries Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2.
Finland
13.6.6.5.3.
Iceland
13.6.6.5.4. Sweden
13.6.6.5.5.
Norway
13.6.7. Benelux Union
13.6.7.1.
Benelux Union Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.7.1.1. Software
13.6.7.1.1.1.
On Premise
13.6.7.1.1.2.
Cloud
13.6.7.1.2. Services
13.6.7.2.
Benelux Union Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
13.6.7.2.1. Stereotactic Radiosurgery (SRS)
13.6.7.2.2.
3-D Conformal Radiation Therapy (3D CRT) 13.6.7.2.3. Brachytherapy
13.6.7.2.4.
Stereotactic Body Radiotherapy (SBRT) 13.6.7.2.5.
Intensity modulated radiation therapy (IMRT)
13.6.7.2.6. Volumetric Modulated Arc Therapy (VMAT) 13.6.7.2.7. Others
13.6.7.3.
Benelux Union Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Organization Size
13.6.7.3.1.
Small and Medium Organizations 13.6.7.3.2. Large Organizations
13.6.7.4.
Benelux Union Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.7.4.1. Hospitals
13.6.7.4.2. Clinics
13.6.7.4.3.
Cancer Treatment Centers 13.6.7.4.4. Others
13.6.7.5.
Benelux Union Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2.
The Netherlands
13.6.7.5.3.
Luxembourg
13.6.8. Rest of Europe
13.6.8.1.
Rest of Europe Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.8.1.1. Software
13.6.8.1.1.1.
On Premise
13.6.8.1.1.2.
Cloud
13.6.8.1.2.
Services
13.6.8.2.
Rest of Europe Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
13.6.8.2.1. Stereotactic Radiosurgery (SRS)
13.6.8.2.2.
3-D Conformal Radiation Therapy (3D CRT) 13.6.8.2.3. Brachytherapy
13.6.8.2.4.
Stereotactic Body Radiotherapy (SBRT) 13.6.8.2.5.
Intensity modulated radiation therapy (IMRT)
13.6.8.2.6. Volumetric Modulated
Arc Therapy (VMAT)
13.6.8.2.7. Others
13.6.8.3.
Rest of Europe Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Organization Size
13.6.8.3.1.
Small and Medium Organizations 13.6.8.3.2. Large Organizations
13.6.8.4.
Rest of Europe Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.8.4.1. Hospitals
13.6.8.4.2.
Clinics
13.6.8.4.3.
Cancer Treatment Centers 13.6.8.4.4. Others
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2.
By Offering
13.7.3.
By Therapy Type
13.7.4. By Organization Size
13.7.5.
By End Users
14. Asia
Pacific Radiation Oncology Treatment Planning Software Market Analysis and Forecasts, 2022 - 2030
14.1. Overview
14.1.1.
Asia Pacific Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn)
14.2.
Asia Pacific Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Offering
14.2.1. Software
14.2.1.1.
On Premise
14.2.1.2.
Cloud
14.2.2.
Services
14.3.
Asia Pacific Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
14.3.1. Stereotactic Radiosurgery (SRS)
14.3.2.
3-D Conformal Radiation Therapy (3D CRT)
14.3.3. Brachytherapy
14.3.4.
Stereotactic Body Radiotherapy (SBRT)
14.3.5. Intensity modulated radiation therapy (IMRT)
14.3.6.
Volumetric Modulated Arc Therapy (VMAT)
14.3.7.
Others
14.4.
Asia Pacific Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Organization Size
14.4.1. Small and Medium Organizations
14.4.2. Large Organizations
14.5.
Asia Pacific Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Hospitals
14.5.2.
Clinics
14.5.3.
Cancer Treatment Centers
14.5.4. Others
14.6.
Asia Pacific Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1.
China Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.1.1.1. Software
14.6.1.1.1.1.
On Premise
14.6.1.1.1.2.
Cloud
14.6.1.1.2.
Services
14.6.1.2.
China Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
14.6.1.2.1. Stereotactic Radiosurgery (SRS)
14.6.1.2.2.
3-D Conformal Radiation Therapy (3D CRT) 14.6.1.2.3. Brachytherapy
14.6.1.2.4.
Stereotactic Body Radiotherapy (SBRT) 14.6.1.2.5.
Intensity modulated radiation therapy (IMRT)
14.6.1.2.6. Volumetric Modulated Arc Therapy (VMAT) 14.6.1.2.7. Others
14.6.1.3.
China Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
14.6.1.3.1.
Small and Medium Organizations 14.6.1.3.2. Large Organizations
14.6.1.4.
China Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.1.4.1. Hospitals
14.6.1.4.2.
Clinics
14.6.1.4.3.
Cancer Treatment Centers 14.6.1.4.4. Others
14.6.2. Japan
14.6.2.1.
Japan Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.2.1.1. Software
14.6.2.1.1.1.
On Premise
14.6.2.1.1.2.
Cloud
14.6.2.1.2. Services
14.6.2.2.
Japan Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
14.6.2.2.1. Stereotactic Radiosurgery (SRS)
14.6.2.2.2.
3-D Conformal Radiation Therapy (3D CRT) 14.6.2.2.3. Brachytherapy
14.6.2.2.4.
Stereotactic Body Radiotherapy (SBRT) 14.6.2.2.5.
Intensity modulated radiation therapy (IMRT)
14.6.2.2.6. Volumetric Modulated Arc Therapy (VMAT) 14.6.2.2.7. Others
14.6.2.3.
Japan Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
14.6.2.3.1.
Small and Medium Organizations 14.6.2.3.2. Large Organizations
14.6.2.4.
Japan Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.2.4.1. Hospitals
14.6.2.4.2.
Clinics
14.6.2.4.3.
Cancer Treatment Centers 14.6.2.4.4. Others
14.6.3. India
14.6.3.1.
India Radiation Oncology Treatment Planning Software Market
Revenue (US$ Mn) and Forecasts, By Offering
14.6.3.1.1. Software
14.6.3.1.1.1.
On Premise
14.6.3.1.1.2.
Cloud
14.6.3.1.2.
Services
14.6.3.2.
India Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
14.6.3.2.1. Stereotactic Radiosurgery (SRS)
14.6.3.2.2.
3-D Conformal Radiation Therapy (3D CRT) 14.6.3.2.3. Brachytherapy
14.6.3.2.4.
Stereotactic Body Radiotherapy (SBRT) 14.6.3.2.5.
Intensity modulated radiation therapy (IMRT)
14.6.3.2.6. Volumetric Modulated Arc Therapy (VMAT) 14.6.3.2.7. Others
14.6.3.3.
India Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
14.6.3.3.1. Small and Medium
Organizations
14.6.3.3.2. Large Organizations
14.6.3.4.
India Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.3.4.1. Hospitals
14.6.3.4.2.
Clinics
14.6.3.4.3.
Cancer Treatment Centers 14.6.3.4.4. Others
14.6.4. New Zealand
14.6.4.1.
New Zealand Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.4.1.1. Software
14.6.4.1.1.1.
On Premise
14.6.4.1.1.2.
Cloud
14.6.4.1.2. Services
14.6.4.2.
New Zealand Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
14.6.4.2.1. Stereotactic Radiosurgery (SRS)
14.6.4.2.2.
3-D Conformal Radiation Therapy (3D CRT) 14.6.4.2.3. Brachytherapy
14.6.4.2.4.
Stereotactic Body Radiotherapy (SBRT) 14.6.4.2.5.
Intensity modulated radiation therapy (IMRT)
14.6.4.2.6. Volumetric Modulated Arc Therapy (VMAT) 14.6.4.2.7. Others
14.6.4.3.
New Zealand Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Organization
Size
14.6.4.3.1.
Small and Medium Organizations 14.6.4.3.2. Large Organizations
14.6.4.4.
New Zealand Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.4.4.1. Hospitals
14.6.4.4.2.
Clinics
14.6.4.4.3.
Cancer Treatment Centers 14.6.4.4.4. Others
14.6.5. Australia
14.6.5.1.
Australia Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.5.1.1. Software
14.6.5.1.1.1.
On Premise
14.6.5.1.1.2.
Cloud
14.6.5.1.2.
Services
14.6.5.2.
Australia Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
14.6.5.2.1. Stereotactic Radiosurgery (SRS)
14.6.5.2.2.
3-D Conformal Radiation Therapy (3D CRT) 14.6.5.2.3. Brachytherapy
14.6.5.2.4.
Stereotactic Body Radiotherapy (SBRT) 14.6.5.2.5.
Intensity modulated radiation therapy (IMRT)
14.6.5.2.6. Volumetric Modulated Arc Therapy (VMAT) 14.6.5.2.7. Others
14.6.5.3.
Australia Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Organization
Size
14.6.5.3.1.
Small and Medium Organizations 14.6.5.3.2. Large Organizations
14.6.5.4.
Australia Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.5.4.1. Hospitals
14.6.5.4.2.
Clinics
14.6.5.4.3.
Cancer Treatment Centers 14.6.5.4.4. Others
14.6.6. South Korea
14.6.6.1.
South Korea Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.6.1.1. Software
14.6.6.1.1.1.
On Premise
14.6.6.1.1.2.
Cloud
14.6.6.1.2.
Services
14.6.6.2.
South Korea Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
14.6.6.2.1. Stereotactic Radiosurgery (SRS)
14.6.6.2.2.
3-D Conformal Radiation Therapy (3D CRT) 14.6.6.2.3. Brachytherapy
14.6.6.2.4.
Stereotactic Body Radiotherapy (SBRT) 14.6.6.2.5.
Intensity modulated radiation therapy (IMRT)
14.6.6.2.6. Volumetric Modulated Arc Therapy (VMAT) 14.6.6.2.7. Others
14.6.6.3.
South Korea Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization
Size
14.6.6.3.1.
Small and Medium Organizations 14.6.6.3.2. Large Organizations
14.6.6.4.
South Korea Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.6.4.1. Hospitals
14.6.6.4.2.
Clinics
14.6.6.4.3.
Cancer Treatment Centers 14.6.6.4.4. Others
14.6.7. Southeast Asia
14.6.7.1.
Southeast Asia Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.7.1.1. Software
14.6.7.1.1.1.
On Premise
14.6.7.1.1.2.
Cloud
14.6.7.1.2. Services
14.6.7.2.
Southeast Asia Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
14.6.7.2.1. Stereotactic Radiosurgery (SRS)
14.6.7.2.2.
3-D Conformal Radiation Therapy (3D CRT) 14.6.7.2.3. Brachytherapy
14.6.7.2.4.
Stereotactic Body Radiotherapy (SBRT) 14.6.7.2.5.
Intensity modulated radiation therapy (IMRT)
14.6.7.2.6. Volumetric Modulated Arc Therapy (VMAT) 14.6.7.2.7. Others
14.6.7.3.
Southeast Asia Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Organization Size
14.6.7.3.1.
Small and Medium Organizations 14.6.7.3.2. Large Organizations
14.6.7.4.
Southeast Asia Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.7.4.1. Hospitals
14.6.7.4.2.
Clinics
14.6.7.4.3.
Cancer Treatment Centers 14.6.7.4.4. Others
14.6.7.5.
Southeast Asia Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3.
Malaysia
14.6.7.5.4.
Singapore
14.6.7.5.5.
Rest of Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1.
Rest of Asia Pacific Radiation Oncology Treatment Planning
Software Market Revenue
(US$ Mn) and Forecasts, By Offering
14.6.8.1.1. Software
14.6.8.1.1.1.
On Premise
14.6.8.1.1.2.
Cloud
14.6.8.1.2.
Services
14.6.8.2.
Rest of Asia Pacific Radiation Oncology Treatment
Planning Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
14.6.8.2.1. Stereotactic Radiosurgery (SRS)
14.6.8.2.2.
3-D Conformal Radiation Therapy (3D CRT) 14.6.8.2.3. Brachytherapy
14.6.8.2.4.
Stereotactic Body Radiotherapy (SBRT) 14.6.8.2.5.
Intensity modulated radiation therapy (IMRT)
14.6.8.2.6. Volumetric Modulated Arc Therapy (VMAT) 14.6.8.2.7. Others
14.6.8.3.
Rest of Asia Pacific Radiation Oncology Treatment
Planning Software Market Revenue (US$ Mn) and Forecasts, By Organization Size
14.6.8.3.1.
Small and Medium Organizations 14.6.8.3.2. Large Organizations
14.6.8.4.
Rest of Asia Pacific Radiation Oncology Treatment
Planning Software Market Revenue
(US$ Mn) and Forecasts, By End Users
14.6.8.4.1. Hospitals
14.6.8.4.2.
Clinics
14.6.8.4.3.
Cancer Treatment Centers 14.6.8.4.4. Others
14.7. Key Segment for Channeling Investments
14.7.1.
By Country
14.7.2.
By Offering
14.7.3. By Therapy Type
14.7.4.
By Organization Size
14.7.5.
By End Users
15. Middle
East and Africa Radiation Oncology Treatment Planning Software Market Analysis and Forecasts, 2022 - 2030
15.1. Overview
15.1.1.
Middle East and Africa Radiation Oncology Treatment
Planning Software Market Revenue (US$ Mn)
15.2.
Middle East and Africa Radiation Oncology Treatment
Planning Software Market Revenue (US$ Mn) and Forecasts, By Offering
15.2.1. Software
15.2.1.1.
On Premise
15.2.1.2.
Cloud
15.2.2. Services
15.3.
Middle East and Africa Radiation Oncology Treatment
Planning Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
15.3.1. Stereotactic Radiosurgery (SRS)
15.3.2.
3-D Conformal Radiation Therapy (3D CRT)
15.3.3. Brachytherapy
15.3.4.
Stereotactic Body Radiotherapy (SBRT)
15.3.5.
Intensity modulated radiation
therapy (IMRT)
15.3.6.
Volumetric Modulated Arc Therapy (VMAT)
15.3.7.
Others
15.4.
Middle East and Africa Radiation Oncology Treatment
Planning Software Market Revenue (US$ Mn) and Forecasts, By Organization Size
15.4.1. Small and Medium
Organizations
15.4.2.
Large Organizations
15.5.
Middle East and Africa Radiation Oncology Treatment
Planning Software Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1. Hospitals
15.5.2.
Clinics
15.5.3. Cancer Treatment Centers
15.5.4.
Others
15.6.
Middle East and Africa Radiation Oncology Treatment
Planning Software Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1.
Saudi Arabia Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.1.1.1. Software
15.6.1.1.1.1.
On Premise
15.6.1.1.1.2.
Cloud
15.6.1.1.2.
Services
15.6.1.2.
Saudi Arabia Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
15.6.1.2.1. Stereotactic Radiosurgery (SRS)
15.6.1.2.2.
3-D Conformal Radiation Therapy (3D CRT) 15.6.1.2.3. Brachytherapy
15.6.1.2.4.
Stereotactic Body Radiotherapy (SBRT) 15.6.1.2.5.
Intensity modulated radiation therapy (IMRT)
15.6.1.2.6. Volumetric Modulated Arc Therapy (VMAT) 15.6.1.2.7. Others
15.6.1.3.
Saudi Arabia Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Organization
Size
15.6.1.3.1.
Small and Medium Organizations 15.6.1.3.2. Large Organizations
15.6.1.4.
Saudi Arabia Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.1.4.1. Hospitals
15.6.1.4.2.
Clinics
15.6.1.4.3.
Cancer Treatment Centers 15.6.1.4.4. Others
15.6.2. UAE
15.6.2.1.
UAE Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.2.1.1. Software
15.6.2.1.1.1.
On Premise
15.6.2.1.1.2.
Cloud
15.6.2.1.2.
Services
15.6.2.2.
UAE Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
15.6.2.2.1. Stereotactic Radiosurgery (SRS)
15.6.2.2.2.
3-D Conformal Radiation Therapy (3D CRT) 15.6.2.2.3. Brachytherapy
15.6.2.2.4.
Stereotactic Body Radiotherapy (SBRT) 15.6.2.2.5.
Intensity modulated radiation therapy (IMRT)
15.6.2.2.6. Volumetric Modulated Arc Therapy (VMAT) 15.6.2.2.7. Others
15.6.2.3.
UAE Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
15.6.2.3.1.
Small and Medium Organizations 15.6.2.3.2. Large Organizations
15.6.2.4.
UAE Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.2.4.1. Hospitals
15.6.2.4.2. Clinics
15.6.2.4.3.
Cancer Treatment Centers 15.6.2.4.4. Others
15.6.3. Egypt
15.6.3.1.
Egypt Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.3.1.1. Software
15.6.3.1.1.1.
On Premise
15.6.3.1.1.2.
Cloud
15.6.3.1.2.
Services
15.6.3.2.
Egypt Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
15.6.3.2.1. Stereotactic Radiosurgery (SRS)
15.6.3.2.2.
3-D Conformal Radiation Therapy (3D CRT) 15.6.3.2.3. Brachytherapy
15.6.3.2.4.
Stereotactic Body Radiotherapy (SBRT) 15.6.3.2.5.
Intensity modulated radiation therapy (IMRT)
15.6.3.2.6. Volumetric Modulated Arc Therapy (VMAT) 15.6.3.2.7. Others
15.6.3.3.
Egypt Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
15.6.3.3.1.
Small and Medium Organizations 15.6.3.3.2. Large Organizations
15.6.3.4.
Egypt Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.3.4.1. Hospitals
15.6.3.4.2.
Clinics
15.6.3.4.3.
Cancer Treatment Centers 15.6.3.4.4. Others
15.6.4. Kuwait
15.6.4.1.
Kuwait Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.4.1.1. Software
15.6.4.1.1.1.
On Premise
15.6.4.1.1.2.
Cloud
15.6.4.1.2.
Services
15.6.4.2.
Kuwait Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
15.6.4.2.1. Stereotactic Radiosurgery (SRS)
15.6.4.2.2.
3-D Conformal Radiation Therapy (3D CRT) 15.6.4.2.3. Brachytherapy
15.6.4.2.4.
Stereotactic Body Radiotherapy (SBRT) 15.6.4.2.5.
Intensity modulated radiation therapy (IMRT)
15.6.4.2.6. Volumetric Modulated Arc Therapy (VMAT) 15.6.4.2.7. Others
15.6.4.3.
Kuwait Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
15.6.4.3.1.
Small and Medium Organizations 15.6.4.3.2. Large Organizations
15.6.4.4.
Kuwait Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.4.4.1. Hospitals
15.6.4.4.2.
Clinics
15.6.4.4.3.
Cancer Treatment Centers 15.6.4.4.4. Others
15.6.5. South Africa
15.6.5.1.
South Africa Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.5.1.1. Software
15.6.5.1.1.1.
On Premise
15.6.5.1.1.2.
Cloud
15.6.5.1.2.
Services
15.6.5.2.
South Africa Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
15.6.5.2.1. Stereotactic Radiosurgery (SRS)
15.6.5.2.2.
3-D Conformal Radiation Therapy (3D CRT) 15.6.5.2.3. Brachytherapy
15.6.5.2.4.
Stereotactic Body Radiotherapy (SBRT) 15.6.5.2.5.
Intensity modulated radiation therapy (IMRT)
15.6.5.2.6. Volumetric Modulated Arc Therapy (VMAT) 15.6.5.2.7. Others
15.6.5.3.
South Africa Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Organization
Size
15.6.5.3.1.
Small and Medium Organizations 15.6.5.3.2. Large Organizations
15.6.5.4.
South Africa Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.5.4.1. Hospitals
15.6.5.4.2.
Clinics
15.6.5.4.3.
Cancer Treatment Centers 15.6.5.4.4. Others
15.6.6. Rest of Middle East & Africa
15.6.6.1.
Rest of Middle East & Africa Radiation Oncology
Treatment Planning Software Market Revenue
(US$ Mn) and Forecasts, By Offering
15.6.6.1.1. Software
15.6.6.1.1.1.
On Premise
15.6.6.1.1.2.
Cloud
15.6.6.1.2. Services
15.6.6.2.
Rest of Middle East & Africa Radiation Oncology
Treatment Planning Software Market
Revenue (US$ Mn) and Forecasts, By Therapy Type
15.6.6.2.1. Stereotactic Radiosurgery (SRS)
15.6.6.2.2.
3-D Conformal Radiation Therapy (3D CRT) 15.6.6.2.3. Brachytherapy
15.6.6.2.4.
Stereotactic Body Radiotherapy (SBRT) 15.6.6.2.5.
Intensity modulated radiation therapy (IMRT)
15.6.6.2.6. Volumetric Modulated Arc Therapy (VMAT) 15.6.6.2.7. Others
15.6.6.3.
Rest of Middle East & Africa Radiation Oncology
Treatment Planning Software Market
Revenue (US$ Mn) and Forecasts, By Organization Size
15.6.6.3.1.
Small and Medium Organizations 15.6.6.3.2. Large Organizations
15.6.6.4.
Rest of Middle East & Africa Radiation Oncology
Treatment Planning Software Market
Revenue (US$ Mn) and Forecasts, By End Users
15.6.6.4.1. Hospitals
15.6.6.4.2. Clinics
15.6.6.4.3.
Cancer Treatment Centers 15.6.6.4.4. Others
15.7. Key Segment for Channeling Investments
15.7.1.
By Country
15.7.2. By Offering
15.7.3.
By Therapy Type
15.7.4.
By Organization Size
15.7.5.
By End Users
16. Latin
America Radiation Oncology Treatment Planning Software Market Analysis and Forecasts, 2022 - 2030
16.1. Overview
16.1.1.
Latin America Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn)
16.2.
Latin America Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Offering
16.2.1. Software
16.2.1.1.
On Premise
16.2.1.2.
Cloud
16.2.2.
Services
16.3.
Latin America Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
16.3.1. Stereotactic Radiosurgery (SRS)
16.3.2. 3-D Conformal Radiation Therapy
(3D CRT)
16.3.3. Brachytherapy
16.3.4.
Stereotactic Body Radiotherapy (SBRT)
16.3.5.
Intensity modulated radiation
therapy (IMRT)
16.3.6. Volumetric Modulated Arc Therapy (VMAT)
16.3.7.
Others
16.4.
Latin America Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Organization Size
16.4.1. Small and Medium
Organizations
16.4.2.
Large Organizations
16.5.
Latin America Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By End Users
16.5.1. Hospitals
16.5.2.
Clinics
16.5.3.
Cancer Treatment Centers
16.5.4.
Others
16.6.
Latin America Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1.
Brazil Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Offering
16.6.1.1.1. Software
16.6.1.1.1.1.
On Premise
16.6.1.1.1.2.
Cloud
16.6.1.1.2.
Services
16.6.1.2.
Brazil Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
16.6.1.2.1. Stereotactic Radiosurgery (SRS)
16.6.1.2.2.
3-D Conformal Radiation Therapy (3D CRT) 16.6.1.2.3. Brachytherapy
16.6.1.2.4.
Stereotactic Body Radiotherapy (SBRT) 16.6.1.2.5.
Intensity modulated radiation therapy (IMRT)
16.6.1.2.6. Volumetric Modulated Arc Therapy (VMAT) 16.6.1.2.7. Others
16.6.1.3.
Brazil Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By Organization Size
16.6.1.3.1.
Small and Medium Organizations 16.6.1.3.2. Large Organizations
16.6.1.4.
Brazil Radiation Oncology Treatment Planning Software
Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.1.4.1. Hospitals
16.6.1.4.2. Clinics
16.6.1.4.3.
Cancer Treatment Centers 16.6.1.4.4. Others
16.6.2. Argentina
16.6.2.1.
Argentina Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Offering
16.6.2.1.1. Software
16.6.2.1.1.1.
On Premise
16.6.2.1.1.2.
Cloud
16.6.2.1.2.
Services
16.6.2.2.
Argentina Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
16.6.2.2.1. Stereotactic Radiosurgery (SRS)
16.6.2.2.2.
3-D Conformal Radiation Therapy (3D CRT) 16.6.2.2.3. Brachytherapy
16.6.2.2.4.
Stereotactic Body Radiotherapy (SBRT) 16.6.2.2.5.
Intensity modulated radiation therapy (IMRT)
16.6.2.2.6. Volumetric Modulated Arc Therapy (VMAT) 16.6.2.2.7. Others
16.6.2.3.
Argentina Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By Organization Size
16.6.2.3.1.
Small and Medium Organizations 16.6.2.3.2. Large Organizations
16.6.2.4.
Argentina Radiation Oncology Treatment Planning
Software Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.2.4.1. Hospitals
16.6.2.4.2.
Clinics
16.6.2.4.3.
Cancer Treatment Centers 16.6.2.4.4. Others
16.6.3. Rest of Latin America
16.6.3.1.
Rest of Latin America Radiation Oncology Treatment
Planning Software Market Revenue
(US$ Mn) and Forecasts, By Offering
16.6.3.1.1. Software
16.6.3.1.1.1.
On Premise
16.6.3.1.1.2.
Cloud
16.6.3.1.2. Services
16.6.3.2.
Rest of Latin America Radiation Oncology Treatment
Planning Software Market Revenue (US$ Mn) and Forecasts, By Therapy Type
16.6.3.2.1. Stereotactic Radiosurgery (SRS)
16.6.3.2.2.
3-D Conformal Radiation Therapy (3D CRT) 16.6.3.2.3. Brachytherapy
16.6.3.2.4.
Stereotactic Body Radiotherapy (SBRT) 16.6.3.2.5.
Intensity modulated radiation therapy (IMRT)
16.6.3.2.6. Volumetric Modulated Arc Therapy (VMAT) 16.6.3.2.7. Others
16.6.3.3.
Rest of Latin America Radiation Oncology Treatment
Planning Software Market Revenue (US$ Mn) and Forecasts, By Organization Size
16.6.3.3.1.
Small and Medium Organizations 16.6.3.3.2. Large Organizations
16.6.3.4.
Rest of Latin America Radiation Oncology Treatment
Planning Software Market Revenue
(US$ Mn) and Forecasts, By End Users
16.6.3.4.1. Hospitals
16.6.3.4.2.
Clinics
16.6.3.4.3.
Cancer Treatment Centers 16.6.3.4.4. Others
16.7. Key Segment for Channeling Investments
16.7.1.
By Country
16.7.2.
By Offering
16.7.3.
By Therapy Type
16.7.4. By Organization Size
16.7.5.
By End Users
17. Competitive Benchmarking
17.1. Market Share
Analysis, 2021
17.2. Global Presence
and Growth Strategies
17.2.1.
Mergers and Acquisitions
17.2.2.
Product Launches
17.2.3.
Investments Trends
17.2.4. R&D Initiatives
18. Player Profiles
18.1. Accuray Incorporated
18.1.1.
Company Details
18.1.2. Company Overview
18.1.3.
Product Offerings
18.1.4. Key Developments
18.1.5.
Financial Analysis
18.1.6.
SWOT Analysis
18.1.7.
Business Strategies
18.2. Brainlab
18.2.1. Company Details
18.2.2. Company Overview
18.2.3.
Product Offerings
18.2.4.
Key Developments
18.2.5. Financial Analysis
18.2.6.
SWOT Analysis
18.2.7.
Business Strategies
18.3. Cerner Corporation
18.3.1. Company Details
18.3.2.
Company Overview
18.3.3.
Product Offerings
18.3.4. Key Developments
18.3.5.
Financial Analysis
18.3.6.
SWOT Analysis
18.3.7. Business Strategies
18.4. Elekta AB
18.4.1.
Company Details
18.4.2.
Company Overview
18.4.3.
Product Offerings
18.4.4. Key Developments
18.4.5.
Financial Analysis
18.4.6.
SWOT Analysis
18.4.7. Business Strategies
18.5. GMV GROUP,
18.5.1.
Company Details
18.5.2.
Company Overview
18.5.3. Product Offerings
18.5.4.
Key Developments
18.5.5.
Financial Analysis
18.5.6.
SWOT Analysis
18.5.7.
Business Strategies
18.6. Koninklijke Philips
N.V.
18.6.1.
Company Details
18.6.2. Company Overview
18.6.3.
Product Offerings
18.6.4.
Key Developments
18.6.5.
Financial Analysis
18.6.6. SWOT Analysis
18.6.7.
Business Strategies
18.7. Prowess Inc.
18.7.1. Company Details
18.7.2.
Company Overview
18.7.3.
Product Offerings
18.7.4. Key Developments
18.7.5.
Financial Analysis
18.7.6.
SWOT Analysis
18.7.7.
Business Strategies
18.8. RaySearch Laboratories
18.8.1.
Company Details
18.8.2.
Company Overview
18.8.3. Product Offerings
18.8.4.
Key Developments
18.8.5.
Financial Analysis
18.8.6. SWOT Analysis
18.8.7.
Business Strategies
18.9. Siemens Healthcare Private Limited
18.9.1.
Company Details
18.9.2.
Company Overview
18.9.3. Product Offerings
18.9.4.
Key Developments
18.9.5.
Financial Analysis
18.9.6. SWOT Analysis
18.9.7.
Business Strategies
18.10.
Varian Medical Systems,
Inc.
18.10.1.
Company Details
18.10.2.
Company Overview
18.10.3.
Product Offerings
18.10.4.
Key Developments
18.10.5.
Financial Analysis
18.10.6.
SWOT Analysis
18.10.7.
Business Strategies
18.11.
Other Market Participants
19. Key Findings
Note:
This ToC is tentative and can be changed according to the research study
conducted during the course of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.